Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Growth Report 2032

Non-Invasive Prenatal Testing (NIPT) Market

Non-Invasive Prenatal Testing (NIPT) Market By Test Type (Panel 1, Panel 2 And Panel 3) And End-Users (Hospitals, Diagnostic Centers And Maternity Clinics): Global Industry Perspective, Comprehensive Analysis And Forecast, 2024 - 2032

Category: Pharmaceutical Report Format : PDF Pages: 130 Report Code: ZMR-2512 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 6.29 Billion USD 19.21 Billion 13.2% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Test Type
        • 2.1.1.2. Market Attractiveness Analysis, By End-User
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Non-Invasive Prenatal Testing (NIPT) Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Non-Invasive Prenatal Testing (NIPT) Market – Test Type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Test Type, 2020 & 2028
    • 4.2. Panel 1
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. PANEL 2
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Panel 3
      • 4.4.1. Market Size and Forecast, By Region (USD Million)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Non-Invasive Prenatal Testing (NIPT) Market – End User Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End-User, 2020 & 2028
    • 5.2. Hospitals
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Diagnostic Centers
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Maternity Clinics
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Non-Invasive Prenatal Testing (NIPT) Market – Region Segment Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.2.2. North America Market Revenue, By Test Type, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End-User, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Test Type, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By End-User, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Test Type, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By End-User, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Test Type, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By End-User, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.3.2. Europe Market Revenue, By Test Type, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End-User, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Test Type, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By End-User, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Test Type, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By End-User, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Test Type, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By End-User, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Test Type, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By End-User, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Test Type, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By End-User, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Test Type, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By End-User, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.4.2. Asia Pacific Market Revenue, By Test Type, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End-User, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Test Type, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By End-User, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Test Type, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By End-User, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Test Type, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By End-User, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Test Type, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By End-User, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Test Type, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By End-User, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Test Type, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End-User, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.5.2. Latin America Market Revenue, By Test Type, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End-User, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Test Type, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By End-User, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Test Type, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By End-User, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Test Type, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By End-User, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Test Type, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End-User, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Test Type, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By End-User, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Test Type, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By End-User, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Test Type, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By End-User, 2016 – 2028
  • Chapter No. 7: Non-Invasive Prenatal Testing (NIPT) Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. By End-User Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Non-Invasive Prenatal Testing (NIPT) Market: Company Market Share, 2019
      • 8.1.2. Global Non-Invasive Prenatal Testing (NIPT) Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 8.1.3. Global Non-Invasive Prenatal Testing (NIPT) Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Non-Invasive Prenatal Testing (NIPT) Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Ariosa Diagnostics, Inc.
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Genesis Genetics (CooperSurgical, Inc.)
    • 9.3. Natera, Inc.
    • 9.4. Centogene N.V.
    • 9.5. Illumina, Inc. (Verinata Health, Inc.)
    • 9.6. Eurofins LifeCodexx GmbH
    • 9.7. MedGenome Labs Ltd.
    • 9.8. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
    • 9.9. Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)
    • 9.10. Progenity, Inc.
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Test Type
FIG NO. 2. Market Attractiveness Analysis, By End-User
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global  Non-Invasive Prenatal Testing (NIPT) Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Test Type, 2020 & 2028 
FIG NO. 7. Global  Non-Invasive Prenatal Testing (NIPT) Market for Panel 1, Revenue (USD Million) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of  Non-Invasive Prenatal Testing (NIPT) Market for Panel 1, By Country, 2020 & 2028
FIG NO. 9. Global  Non-Invasive Prenatal Testing (NIPT) Market for Panel 2, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of  Non-Invasive Prenatal Testing (NIPT) Market for Panel 2, By Country, 2020 & 2028
FIG NO. 9. Global  Non-Invasive Prenatal Testing (NIPT) Market for Panel 3, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of  Non-Invasive Prenatal Testing (NIPT) Market for Panel 3, By Country, 2020 & 2028
FIG NO. 11. Market Revenue Share, By End-User, 2020 & 2028
FIG NO. 12. Global  Non-Invasive Prenatal Testing (NIPT) Market for Hospitals, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of  Non-Invasive Prenatal Testing (NIPT) Market for Hospitals, By Country, 2020 & 2028 
FIG NO. 14. Global  Non-Invasive Prenatal Testing (NIPT) Market for Diagnostic Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of  Non-Invasive Prenatal Testing (NIPT) Market for Diagnostic Centers, By Country, 2020 & 2028
FIG NO. 16. Global  Non-Invasive Prenatal Testing (NIPT) Market for Maternity Clinics, Revenue (USD Million) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of  Non-Invasive Prenatal Testing (NIPT) Market for Maternity Clinics, By Country, 2020 & 2028
FIG NO. 18. Global  Non-Invasive Prenatal Testing (NIPT) Market Revenue Share, By Region, 2020 & 2028
FIG NO. 19. North America  Non-Invasive Prenatal Testing (NIPT) Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 20. Porter’s Five Forces Analysis for Global  Non-Invasive Prenatal Testing (NIPT) Market
FIG NO. 21. PEST Analysis for Global  Non-Invasive Prenatal Testing (NIPT) Market
FIG NO. 22. Pricing Analysis for Global  Non-Invasive Prenatal Testing (NIPT) Market
FIG NO. 23. Value Chain Analysis for Global  Non-Invasive Prenatal Testing (NIPT) Market
FIG NO. 24. Company Share Analysis, 2019
FIG NO. 25. Radar Determinant Chart, 2019
FIG NO. 26. Company Strategic Developments – Heat Map Analysis
FIG NO. 27. Business Segment Revenue Share, 2020 (%)
FIG NO. 28. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 29. Market Channels
FIG NO. 30. Marketing Channel Development Trend
FIG NO. 31. Growth in World Gross Product, 2008-2018
FIG NO. 32. Research Methodology – Detailed View
FIG NO. 33. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global  Non-Invasive Prenatal Testing (NIPT) Market: Snapshot
TABLE NO. 2. Quarterly  Non-Invasive Prenatal Testing (NIPT) Market Revenue by Region, 2020
TABLE NO. 3. Quarterly  Non-Invasive Prenatal Testing (NIPT) Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million) 
TABLE NO. 6. Global  Non-Invasive Prenatal Testing (NIPT) Market for Panel 1, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global  Non-Invasive Prenatal Testing (NIPT) Market for PANEL 2, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8. Global  Non-Invasive Prenatal Testing (NIPT) Market for Panel 3, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9. Global  Non-Invasive Prenatal Testing (NIPT) Market for Hospitals, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10 Global  Non-Invasive Prenatal Testing (NIPT) Market for Diagnostic Centers, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global  Non-Invasive Prenatal Testing (NIPT) Market for Maternity Clinics, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12 Global  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 13. North America  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 14. North America  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 15. North America  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 16. U.S.  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 17. U.S.  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 18. Canada  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 19. Canada  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 20. Mexico  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 21. Mexico  Non-Invasive Prenatal Testing (NIPT) Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 22. Drivers for the  Non-Invasive Prenatal Testing (NIPT) Market: Impact Analysis
TABLE NO. 23. Restraints for the  Non-Invasive Prenatal Testing (NIPT) Market: Impact Analysis
TABLE NO. 24. Major Buyers of  Non-Invasive Prenatal Testing (NIPT)
TABLE NO. 25. Distributors/Traders List of  Non-Invasive Prenatal Testing (NIPT)
TABLE NO. 26. Global  Non-Invasive Prenatal Testing (NIPT) Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 27: Global  Non-Invasive Prenatal Testing (NIPT) Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)   


 

Methodology

FrequentlyAsked Questions

The global Non-Invasive Prenatal Testing (NIPT) Market was valued at USD 6.29 Billion in 2023.

The global Non-Invasive Prenatal Testing (NIPT) Market is expected to reach USD 19.21 Billion by 2032, with a CAGR of around 13.2% between 2024-2032.

The increasing incidence of chromosomal abnormalities coupled with growing product usage in new applications is driving the organic revenue growth in the market.

North America in 2023 ruled the Non-Invasive Prenatal Testing (NIPT) market and was believed to be the highest income-generating area all over the globe.

The major players that are comprised in Non-Invasive Prenatal Testing (NIPT) market are Ariosa Diagnostics, Inc., Berry Genomics Co., Ltd, BGI Diagnostics, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom Laboratories, and Quest Diagnostics, Inc.

  • zion payment modes

List of Contents

Market InsightsMarket Overview Growth Factors Report ScopeSegment Analysis Preview Regional Analysis PreviewKey Market Players Competitive LandscapeThe global Market is segmented as follows:

HappyClients